The International Hospital Federation (IHF) has announced that the 47th World Hospital Congress will be held in Rio de Janeiro, Brazil, in September 2024.
Viz.ae, a leader in AI-powered disease detection and intelligent care coordination, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA). Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected AAA.
In search for new ways to accommodate a larger student body and fulfil workforce demands, nursing schools are developing new approaches to optimize learning, engage student nurses, and provide methods to ensure competency in future nursing graduates.
Mind-body connection: A new study from researchers at Washington University School of Medicine in St. Louis suggests that the link between body and mind is not just an abstraction.
The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium, has named Simon Mason as its new President. In his new role, Mr. Mason will lead strategy and operations for NESTcc to serve its stakeholders, including patients, providers, payers, medical device manufacturers, regulators, and others.
FUJIFILM Healthcare Europe is consolidating its commercial activities in Belgium, the Netherlands and Luxembourg effective 31 March. This change reflects the first step of a phased integration between Fujifilm Europe Medical Systems and FUJIFILM Healthcare Europe, to form the unified FUJIFILM Healthcare Europe, with further integration continuing throughout 2023 and 2024.
Orion Health is strengthening its presence in France with the appointment of digital health industry heavyweight, Tristan Debove, to lead its operations.
HeartKit™, Built on Ambiq’s AI SDK, neuralSPOT®, Enables Efficient Real-Time Heart Monitoring Applications
Curasight to develop its proprietary uTRACE® PET imaging technology to obtain regulatory approval in EU and USA, with Curium responsible for manufacturing and commercialization Curasight eligible for up to USD 70 mn in development and commercial milestones as well as double-digit royalties on sales on eventual commercialization The agreement supports Curasight’s strategy to leverage partnerships as it […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
